Hamilton Thorne Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Kate Torchilin

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	less than a year
Participación del CEO	n/a
Permanencia media de la dirección	less than a year
Promedio de permanencia en la Junta Directiva	3.3yrs

Actualizaciones recientes de la dirección

Recent updates

CEO

Kate Torchilin

less than a year

Permanencia

Ms. Ekaterina Torchilin PhD, MBA, also known as Kate, is President, Chief Executive Officer and Director of Hamilton Thorne Ltd. from January 15, 2024. She serves as Chief Executive Officer of Biocell Cent...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
David Wolf	Executive Chairman	12.7yrs	US$536.59k	2.14% $ 3.0m
Francesco Fragasso	Chief Financial Officer	1.7yrs	US$151.26k	0.018% $ 26.0k
Brett Fulton	Senior VP & GM	3yrs	US$300.60k	sin datos
Ekaterina Torchilin	President	less than a year	sin datos	sin datos
Thomas Kenny	Senior Vice President Global Operations & Sustaining Engineering and Management Rep	no data	US$165.49k	sin datos
Justin Jaundoo	Vice President of Corporate Development	no data	sin datos	sin datos
Kimberly Marolda	Director of HR	no data	sin datos	sin datos
Eric Dorman	President of Embryotech Laboratories Inc	no data	sin datos	sin datos
Fabian Sell	Chief Executive Officer of Gynemed	no data	US$282.51k	sin datos
Dan Ryan	Finance Controller	no data	sin datos	sin datos

1.0yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de 0ZM no se considera experimentado ( 0.9 años antigüedad media), lo que sugiere un nuevo equipo.

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
David Wolf	Executive Chairman	12.7yrs	US$536.59k	2.14% $ 3.0m
Ekaterina Torchilin	President	less than a year	sin datos	sin datos
Robert Potter	Lead Independent Director	14.6yrs	US$47.50k	0.32% $ 451.9k
Daniel Thorne	Independent Director	14.6yrs	sin datos	13.25% $ 18.7m
Bruno Maruzzo	Independent Director	17.2yrs	US$37.50k	0.17% $ 239.0k
Karen Firestone	Independent Director	2.3yrs	US$47.50k	0.060% $ 85.1k
David Sable	Independent Director	7.3yrs	sin datos	0.096% $ 134.9k
Marc Robinson	Independent Director	3.3yrs	sin datos	0.031% $ 43.4k
Meg Spencer	Chairman Emeritus	1.8yrs	sin datos	sin datos
Cynthia Hudson	Member of Scientific Advisory Board	3.1yrs	sin datos	sin datos
Feng Han	Independent Director	3.3yrs	US$47.50k	0.064% $ 90.2k
Thomas Ebner	Member of Scientific Advisory Board	3.1yrs	sin datos	sin datos

3.3yrs

Permanencia media

70yo

Promedio de edad

Junta con experiencia: La junta directiva de 0ZM se considera experimentada (3.2 años de antigüedad promedio).

Hamilton Thorne Dirección

Dirección controles de criterios 1/4

Información clave

Actualizaciones recientes de la dirección

Hamilton Thorne Ltd., Annual General Meeting, Jun 11, 2024

Hamilton Thorne Ltd. Announces CEO Changes, Effective January 15, 2024

Chair, President & CEO recently sold €69k worth of stock

Hamilton Thorne Ltd. Announces Passing of Diarmaid Douglas-Hamilton, Cofounder and Chief Technology Officer

High number of new directors

Hamilton Thorne Ltd. Announces CFO Changes

Recent updates

Hamilton Thorne Ltd. to Report Q1, 2024 Results on May 14, 2024

Hamilton Thorne Ltd., Annual General Meeting, Jun 11, 2024

Full year 2023 earnings released: US$0.004 loss per share (vs US$0.013 profit in FY 2022)

Hamilton Thorne Ltd. Provides Earnings Guidance for the First Quarter 2024 and Full Twelve Months of 2024

Hamilton Thorne Ltd. to Report Q4, 2023 Results on Mar 27, 2024

Hamilton Thorne Ltd. Announces CEO Changes, Effective January 15, 2024

New major risk - Revenue and earnings growth

Third quarter 2023 earnings released: US$0.005 loss per share (vs US$0.001 profit in 3Q 2022)

Hamilton Thorne Ltd. to Report Q3, 2023 Results on Nov 13, 2023

Hamilton Thorne Ltd. (TSX:HTL) agreed to acquire Gynetics Medical Products N.V. for an enterprise value of €18.3 million.

New minor risk - Shareholder dilution

Hamilton Thorne Ltd.(TSXV:HTL) dropped from S&P/TSX Venture Composite Index

Second quarter 2023 earnings released: US$0.003 loss per share (vs US$0.002 profit in 2Q 2022)

Hamilton Thorne Ltd. to Report Q2, 2023 Results on Aug 17, 2023

New minor risk - Share price stability

First quarter 2023 earnings released: EPS: US$0.001 (vs US$0.004 in 1Q 2022)

Now 20% undervalued

Hamilton Thorne Ltd. to Report Q1, 2023 Results on May 15, 2023

Now 20% undervalued

Chair, President & CEO recently sold €69k worth of stock

Now 21% undervalued after recent price drop

Full year 2022 earnings released: EPS: US$0.013 (vs US$0.017 in FY 2021)

Now 21% undervalued

Now 24% undervalued after recent price drop

Hamilton Thorne Ltd. Announces Passing of Diarmaid Douglas-Hamilton, Cofounder and Chief Technology Officer

Now 22% undervalued after recent price drop

Hamilton Thorne Ltd. (TSXV:HTL) agreed to acquire Microptic, S.L.

Third quarter 2022 earnings released: EPS: US$0.001 (vs US$0.002 in 3Q 2021)

Hamilton Thorne Ltd. Provides Sales Guidance for the Year 2022

High number of new directors

Hamilton Thorne Ltd. to Report Nine Months, 2022 Results on Nov 22, 2022

Second quarter 2022 earnings released: EPS: US$0.002 (vs US$0.003 in 2Q 2021)

Hamilton Thorne Ltd. to Report Q2, 2022 Results on Aug 23, 2022

Hamilton Thorne Ltd. Announces CFO Changes

First quarter 2022 earnings released: EPS: US$0.004 (vs US$0.006 in 1Q 2021)

Hamilton Thorne Ltd. to Report Q1, 2022 Results on May 19, 2022

High number of new directors

Hamilton Thorne Ltd., Annual General Meeting, Jun 14, 2022

Full year 2021 earnings released: EPS: US$0.017 (vs US$0.007 in FY 2020)

Hamilton Thorne Ltd. to Report Q4, 2021 Results on Apr 07, 2022

High number of new directors

President recently bought €52k worth of stock

President recently sold €440k worth of stock

Third quarter 2021 earnings: EPS in line with expectations, revenues disappoint

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS US$0.003 (vs US$0.004 loss in 2Q 2020)

Hamilton Thorne Ltd. (TSXV:HTL) acquired IVFTECH ApS and K4 Technology ApS for an enterprise value of approximately DKK 50 million ($8 million).

First quarter 2021 earnings released: EPS US$0.006 (vs US$0.001 in 1Q 2020)

Independent Director recently bought €71k worth of stock

Full year 2020 earnings released: EPS US$0.007 (vs US$0.006 in FY 2019)

Hamilton Thorne Ltd. Announces Board Changes

Hamilton Thorne Announces Board Changes

Third quarter 2020 earnings released: EPS US$0.003

Revenue beats expectations

Hamilton Thorne Ltd. to Report Q3, 2020 Results on Nov 19, 2020

New 90-day high: €0.92

President recently sold €176k worth of stock

New 90-day high - €0.91

Earnings released

Hamilton Thorne Ltd. to Report Q2, 2020 Results on Aug 20, 2020

New 90-day high - €0.86

CEO

Permanencia

Equipo directivo

Permanencia media

Miembros de la Junta

Permanencia media

Promedio de edad